abbvie glp-1 receptor agonist medications Mapping the effectiveness and risks of agonists Benefits and Risks of GLP-1

[15] In both trials, after 72 weeks of treatment, participants who received tirzepatide at all three dose levels experienced a statistically significant reduction in body weight compared to those who received placebo, and greater proportions of participants who received tirzepatide achieved at least 5% weight reduction compared to placebo

Arbutin: A gentle, plant-based alternative to hydroquinone that effectively fades melasma patches

Osmotic regulation In response to an increase in osmotic stress, the intracellular level of taurine is elevated, while it reduces stress due to hypo-osmosis

A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association

Aging Cell

J.AtkinsonC.BhallaK.BirbeckG.BursteinR.ChouD.et al (2013)